Trials / Recruiting
RecruitingNCT06745609
Prehabilitation Prior to Surgery for Kidney Tumors
Prehabilitation Prior to Surgery for Kidney Tumors: A Randomized Controlled Research Study (Pre-KiT)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Herlev and Gentofte Hospital · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to examine if one month of general health optimization before surgery for kidney tumors can help participants recover more quickly from surgery. The optimization process is called prehabiliation, and will last one month. It consists of 1. A comprehensive health assessment 2. Assisted smoking cessation 3. A home exercise program. The investigators will compare an intervention group receiving one month of prehabilitation with a control group receiving the standard of care. Some of the main questions the investigators want to answer are * Are participants in the intervention group more satisfied with their quality of recovery after surgery? * Do participants in the intervention group maintain more of their physical abilites compared to the control group?
Conditions
- Renal Cancer
- Renal Cell Cancer
- Kidney Cancers
- Stage I Renal Cell Cancer
- Prehabilitation
- Elderly (People Aged 65 or More)
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Prehabilitation | Pre-KiT prehabilitation consists of 1. A geriatric guided assessment with relevant interventions. The assessment will include cognitive evaluation, screening for depression, functional assessment, as well as evaluation of nutritional risk, assessment of past and current diseases, and a thorough review of the patient's medication list focusing on drug interactions. It will also include social history and standard laboratory results, 2. Physical activity. A four week home exercise program, adjusted to the participants physical abilities. 3. Assisted smoking cessation |
Timeline
- Start date
- 2025-01-21
- Primary completion
- 2027-03-01
- Completion
- 2032-03-01
- First posted
- 2024-12-20
- Last updated
- 2025-01-24
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT06745609. Inclusion in this directory is not an endorsement.